#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Peripheral primitive neuroectodermal tumour of soft tissue Crohn's disease Hypomagnesaemia Neuroendocrine cell hyperplasia of infancy Acute respiratory distress syndrome Cluster headache Renal cell carcinoma Inflammatory myofibroblastic tumour Juvenile chronic myelomonocytic leukaemia Glomerulonephritis acute Osteosarcoma Erdheim-Chester disease Fms-like tyrosine kinase 3 positive Cytokine release syndrome Thrombocytopenia More trials…

    Learn about Rare Diseases

    Hyperoxaluria – Treatment Glomerulonephritis rapidly progressive – Trials in Disease Waldenstrom’s macroglobulinaemia refractory – Life with Disease Hairy cell leukaemia recurrent – Diagnostics Burkitt’s lymphoma – Trials in Disease Activated PI3 kinase delta syndrome Congenital generalised lipodystrophy – Basic Information Factor VIII deficiency – Life with Disease Atypical haemolytic uraemic syndrome – Diagnostics Pemphigus – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Enfortumab Vedotin Methoxsalen Haemophilus Influenzae Citicoline Sodium COLESEVELAM HYDROCHLORIDE Ezabenlimab LY3841136 SODIUM Gfh925 Ciprofloxacin Hydrochloride Nelivaptan Vedolizumab Stx-241 Paraffin White Soft Mirvetuximab Soravtansine Trientine Dihydrochloride Tin816 Immunoglobulin G A3907 Relatlimab Sodium Valproate More therapies…

    Learn about Your Condition

    Spinal pain Renal cancer Pulmonary venous thrombosis Metabolic surgery Drug use disorder Glaucoma Thyroid disorder Mitral valve incompetence Tissue anoxia Cardiac failure chronic Cardiac failure acute Post procedural infection Obstructive pancreatitis Hodgkin's disease recurrent BK virus infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. IRCCS Humanitas Research Hospital

IRCCS Humanitas Research Hospital

Via Alessandro Manzoni 56, Rozzano, 20089, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of Dupilumab for Adults with Chronic Itch of Unknown Cause

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pruritus
    Investigated Drugs:
    • Dupilumab
    • Fexofenadine
    • Loratadine
    France Germany Hungary Italy Poland Spain

  • Study on Long-Term Safety of Trastuzumab Deruxtecan for Patients with Advanced HER2-Positive or HER2-Mutated Solid Tumors

    Recruiting

    3 1 1
    Investigated Diseases:
    • HER2 positive gastric cancer
    • Breast cancer metastatic
    • Colorectal cancer
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    Belgium France Italy Spain

  • Study on the Effectiveness and Safety of Tinengotinib for Patients with Cholangiocarcinoma Resistant to Chemotherapy and FGFR Inhibitors

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cholangiocarcinoma
    Investigated Drugs:
    • Tinengotinib
    • Irinotecan Hydrochloride Trihydrate
    • Fluorouracil
    Austria Belgium France Germany Italy Poland +2

  • Study on the Effectiveness of Volrustomig in Women with High-Risk Locally Advanced Cervical Cancer After Chemoradiation Therapy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cervix carcinoma
    Investigated Drugs:
    • Infliximab
    • Mycophenolate Mofetil
    • Volrustomig
    Denmark Germany Italy Norway Poland Spain

  • Study on Preventing Cardiovascular Collapse in Critically Ill Adults Using Noradrenaline Tartrate During Tracheal Intubation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Noradrenaline Tartrate
    Ireland Italy

  • Study of AZD5305 with Abiraterone Acetate and Darolutamide in Men with Metastatic Castration-Sensitive Prostate Cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    Investigated Drugs:
    • Saruparib
    • Darolutamide
    • Abiraterone Acetate
    Austria Belgium Finland France Germany Hungary +5

  • Study on the Effects of Baricitinib and Drug Combination for Adults with Severe Community-Acquired Pneumonia, Severe Influenza, or Severe and Moderate COVID-19

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Azithromycin
    • Clarithromycin
    • Erythromycin
    Belgium Croatia Czechia Estonia France Germany +7

  • Study on the Effectiveness of Lutetium (177Lu) Vipivotide Tetraxetan with Standard Treatment for Men with Metastatic Hormone-Sensitive Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-dependent prostate cancer
    Investigated Drugs:
    • Apalutamide
    • Darolutamide
    • Lutetium (177Lu) Vipivotide Tetraxetan
    Belgium France Ireland Italy The Netherlands Spain

  • Continued Access Study for Patients with Severe Hemophilia A Using Efanesoctocog Alfa

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Efanesoctocog Alfa
    Bulgaria France Germany Greece Italy The Netherlands +4

  • Study of Tulmimetostat (CPI-0209) for Patients with Advanced Solid Tumors and Lymphomas

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Mesothelioma malignant
    • Lymphoma
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Tulmimetostat
    • Enzalutamide
    France Italy Poland Spain
Previous Page
1 … 21 22 23 24 25 … 69
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!